Caris Life Sciences (CAI) EBIT Margin (2024 - 2026)

Caris Life Sciences' (CAI) quarterly EBIT Margin came in at 2.44% in Q1 2026, up 5037.0% year-on-year from 0.05% in Q1 2025, and down 91.91% quarter-over-quarter from 30.19% in Q4 2025.

Caris Life Sciences (CAI) EBIT Margin (2024 - 2026) Analysis & Trends

Caris Life Sciences' EBIT Margin history runs 3 years deep, the most recent figure standing at 2.44% for Q1 2026.

  • On a quarterly basis, EBIT Margin rose 5037.0% year-over-year to 2.44% in Q1 2026; TTM through Mar 2026 was 11.94%, a 6119.0% increase from a year earlier, with the FY2025 full-year figure at 5.56%, up 6792.0% from the prior year.
  • EBIT Margin retreated to 2.44% in Q1 2026 per CAI's latest filing, from 30.19% in the prior quarter.
  • Across five years, EBIT Margin topped out at 30.19% in Q4 2025 and bottomed at 66.98% in Q2 2024.
  • The 3-year median for EBIT Margin is 19.22% (2024), against an average of 20.69%.
  • Across the five-year window, EBIT Margin jumped 7493 bps in 2025 and surged 5037 bps in 2026, its largest moves.
  • Year by year, EBIT Margin stood at 28.52% in 2024, then soared by 206 bps to 30.19% in 2025, then tumbled by 92 bps to 2.44% in 2026.
  • Per Business Quant, the three latest CAI EBIT Margin figures stand at 2.44% (Q1 2026), 30.19% (Q4 2025), and 15.05% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 16.51%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 38.10%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 17.83%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 31.68%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Caris Life Sciences 4.42 Bn 3.60 Bn 214.23 Mn 2.44%

Historic Data

Download Data
DateValue
Mar 31, 2026 2.44%
Dec 31, 2025 30.19%
Sep 30, 2025 15.05%
Jun 30, 2025 -9.92%
Mar 31, 2025 -47.93%
Dec 31, 2024 -28.52%
Sep 30, 2024 -59.87%
Jun 30, 2024 -66.98%